The Global Beta Low Beta ETF (GBLO) is managed by Global Beta Advisors LLC and is designed to track the performance of the Target Index. The Target Index comprises equity securities of U.S. companies from the S&P 500 that fall within the lowest quintile based on their twelve-month trailing beta relative to the S&P 500. Beta measures a security's relative volatility compared to the broader market. The constituent securities of the Target Index are weighted based on their revenue, with each individual index constituent capped at 5% during quarterly rebalances. As of January 29, 2022, the Target Index consisted of 101 securities.
While the primary objective of the Global Beta Low Beta ETF (GBLO) is to track the performance of the Target Index, it's important to note its dividend distribution characteristics. The ETF's dividend distributions typically follow the patterns of the underlying index constituents, which are selected based on their low beta relative to the S&P 500. Dividends are distributed on a quarterly basis and depend on the individual dividend policies and performance of the stocks within the index. GBLO is designed for investors seeking a low-beta approach with the potential for dividend income, making it a suitable choice for those aiming to balance risk and income within their portfolio.
Tracking the Global Beta Low Beta ETF (GBLO) involves following the performance of the Target Index, which is comprised of equity securities of U.S. companies from the S&P 500 in the lowest quintile based on their twelve-month trailing beta relative to the S&P 500. Beta measures the relative volatility of a security compared to the market. The constituent securities of the Target Index are weighted based on their revenue, with each individual index constituent capped at 5% at each quarterly rebalance. As of January 29, 2022, the Target Index consisted of 101 securities. The GBLO ETF may use either a replication strategy or representative sampling strategy to closely track the Target Index, providing investors exposure to low-beta U.S. equities.
The correlation aspect of the GBLO ETF (Global Beta Low Beta ETF) is primarily driven by its unique strategy of tracking the performance of the Target Index, which consists of equity securities from the lowest quintile of the S&P 500 based on their twelve-month trailing beta relative to the S&P 500. This approach aims to capture low-beta stocks, which tend to exhibit lower volatility compared to the broader market. As a result, GBLO typically shows a lower correlation with the overall U.S. equity market compared to traditional ETFs tracking the entire S&P 500. This makes GBLO an appealing choice for investors seeking lower market risk and potentially better risk-adjusted returns.
The GBLO Sector ETF seeks to track the performance of the Target Index, which is comprised of equity securities of U.S. companies from the S&P 500 in the lowest quintile based on their twelve-month trailing beta relative to the S&P 500. Beta is a measure of relative volatility, and the constituent securities of the Target Index are weighted based on their revenue, with each individual index constituent capped at 5% at each quarterly rebalance. As of January 29, 2022, the Target Index consisted of 101 securities. The Target Index has a concentration in the Health Care and Consumer Staples sectors, which means the ETF will also have a similar sector focus. While this sector concentration may offer potential opportunities, it could lead to higher risk compared to more diversified ETFs. The Fund may use either a replication or representative sampling strategy to track the Target Index, depending on market conditions and practical considerations.
While there is no specific information available regarding the exposure characteristics of the GBLO ETF, investors looking to gain insights into its market, region, and sector exposure can turn to the ETF Insider web app. This tool offers a comprehensive analysis of various US ETFs, providing deep and interesting data through simple visualizations. It enables investors to discover important details, such as overlap and correlations, allowing for more informed investment decisions.
ETF Insider is a data-driven portfolio analytics and optimization platform that introduces a more efficient and practical way to visualize, analyze and optimize portfolios.
Rather than focusing on the surface-level attributes of ETFs and Mutual Funds, ETF Insider goes deeper by examining the underlying holdings of exchange traded products.
By organizing and structuring that data, investors can easily navigate within their overlapping layers.
This innovative perspective combined with modern data visualization and modeling tools, provides an entirely new approach to portfolio optimization that can quickly expose both portfolio inefficiencies and opportunities.
5 min readThe GBLO ETF is a specialized investment fund that focuses on global companies in the relevant sectors. This exchange-traded fund offers investors exposure to a diverse range of innovative and cutting-edge companies engaged in advancements in the industry. Discover the potential growth opportunities and risks associated with investing in this dynamic sector through the GBLO ETF.
4 min readCompare the REET and FREL ETFs with our thorough analysis. Dive into the performance metrics, underlying assets, and investment strategies to see how they stack up against each other. Whether you're a seasoned investor or just getting started, our comparison provides valuable insights to guide your investment decisions.
5 min readThe FXO ETF is a specialized investment fund that focuses on a specific sector. This exchange-traded fund offers investors exposure to a range of companies in this sector.
ETF Insider is a novel portfolio optimization tool that uses the power of data visualization to gain insight into portfolio compositions, concentration risks, portfolio efficiency and more. Complex financial data can be transformed into visually appealing and easily digestible graphs and charts, allowing investors to quickly identify trends and make well-informed investment decisions. Not only does this save time, but it also increases the accuracy and effectiveness of portfolio management.
